Posted by SalArmy4me on July 24, 2001, at 20:41:51
In reply to new to neurontin, posted by Angelique on July 24, 2001, at 16:47:38
I think the neurontin is a good choice, and here's why:
--It can be used for many different mood disorders
--It less drowsiness, sexual side-effects,
--it does not have anticholinergic side-effects
--it comes in many different dosages now (600s and 800s)
--it requires no blood-tests
--it can be titrated quickly
--it has few significant drug interactions
--it has gained the respect of psychiatrists in less than a decade of FDA approval
http://www.psycom.net/depression.central.gabapentin.htmlHere are the studies that prove Neurontin's efficacy:
5: Vieta E, Martinez-Aran A, Nieto E, Colom F, Reinares M, Benabarre A, Gasto C. Adjunctive gabapentin treatment of bipolar disorder.
Eur Psychiatry. 2000 Nov;15(7):433-7.6: Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
J Clin Psychopharmacol. 2000 Dec;20(6):607-14.9: Bennett J, Goldman WT, Suppes T.
Gabapentin for treatment of bipolar and schizo-
affective disorders.
J Clin Psychopharmacol. 1997 Apr;17(2):141-2.10: Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, Taylor CB, Dager SR, Shiovitz T. Placebo-controlled study of gabapentin treatment of panic disorder.
J Clin Psychopharmacol. 2000 Aug;20(4):467-71.15: Brannon N, Labbate L, Huber M.
Gabapentin treatment for posttraumatic stress disorder.
Can J Psychiatry. 2000 Feb;45(1):84.16: Dallocchio C, Buffa C, Mazzarello P.
Combination of donepezil and gabapentin for behavioral
disorders in Alzheimer's disease.
J Clin Psychiatry. 2000 Jan;61(1):64.17: Herrmann N, Lanctot K, Myszak M.
Effectiveness of gabapentin for the treatment of
behavioral disorders in dementia.
J Clin Psychopharmacol. 2000 Feb;20(1):90-3.19: Schaffer CB, Schaffer LC.
Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment.
J Affect Disord. 1999 Oct;55(2-3):237-40.20: Maurer I, Volz HP, Sauer H.
Gabapentin leads to remission of somatoform pain
disorder with major depression.
Pharmacopsychiatry. 1999 Nov;32(6):255-7.21: Sokolski KN, Green C, Maris DE, DeMet EM.
Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology.
Ann Clin Psychiatry. 1999 Dec;11(4):217-22.23: Botts SR, Raskind J.
Gabapentin and lamotrigine in bipolar disorder.
Am J Health Syst Pharm. 1999 Oct 1;56(19):1939-44. Review.24: Magnus L.
Nonepileptic uses of gabapentin.
Epilepsia. 1999;40 Suppl 6:S66-72; discussion S73-4. Review.26: Young LT, Robb JC, Hasey GM, MacQueen GM,
Patelis Siotis I, Marriott M, Joffe RT. <
Gabapentin as an adjunctive treatment in bipolar disorder.
J Affect Disord. 1999 Sep;55(1):73-7.28: Perugi G, Toni C, Ruffolo G, Sartini S, Simonini E, Akiskal H. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states.
Pharmacopsychiatry. 1999 Jul;32(4):136-41. Review.
29: Hardoy MC, Hardoy MJ, Carta MG, Cabras PL. Gabapentin as a promising treatment for antipsychotic-induced movement disorders in schizoaffective and bipolar patients.
J Affect Disord. 1999 Aug;54(3):315-7.30: Harden CL, Lazar LM, Pick LH, Nikolov B, Goldstein MA, Carson D, Ravdin LD, Kocsis JH, Labar DR. A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
Epilepsia. 1999 Aug;40(8):1129-34.31: Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH, Sutherland SM. Treatment of social phobia with gabapentin: a placebo-controlled study.
J Clin Psychopharmacol. 1999 Aug;19(4):341-8.32: Grunze H, Erfurth A, Amann B, Normann C, Walden J. [Gabapentin in the treatment of mania].
Fortschr Neurol Psychiatr. 1999 Jun;67(6):256-60. German.34: Dodrill CB, Arnett JL, Hayes AG, Garofalo EA, Greeley CA, Greiner MJ, Pierce MW.
Cognitive abilities and adjustment with gabapentin: results of a multisite study.
Epilepsy Res. 1999 Jun;35(2):109-21.37: Letterman L, Markowitz JS.
Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions.
Pharmacotherapy. 1999 May;19(5):565-72. Review.38: Cabras PL, Hardoy MJ, Hardoy MC, Carta MG. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study.
J Clin Psychiatry. 1999 Apr;60(4):245-8.40: Hatzimanolis J, Lykouras L, Oulis P, Christodoulou GN.
Gabapentin as monotherapy in the treatment of acute mania.
Eur Neuropsychopharmacol. 1999 Mar;9(3):257-8.45: Erfurth A, Kammerer C, Grunze H, Normann C, Walden J. An open label study of gabapentin in the treatment of acute mania.
J Psychiatr Res. 1998 Sep-Oct;32(5):261-4.46: Dopheide JA, Wincor MZ.
Gabapentin and lamotrigine in the treatment of bipolar disorder.
J Am Pharm Assoc (Wash). 1998 Sep-Oct;38(5):632-4.47: Ferrier IN.
Lamotrigine and gabapentin. Alternative in the treatment of bipolar disorder.
Neuropsychobiology. 1998 Oct;38(3):192-7. Review.49: Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK. Gabapentin treatment of mood disorders: a preliminary study.
J Clin Psychiatry. 1998 Aug;59(8):426-9.53: Pollack MH, Matthews J, Scott EL. <
Gabapentin as a potential treatment for anxiety disorders.
Am J Psychiatry. 1998 Jul;155(7):992-3.55: Soutullo CA, Casuto LS, Keck PE.
Gabapentin in the treatment of adolescent mania: a case report.
J Child Adolesc Psychopharmacol. 1998;8(1):81-5.56: Knoll J, Stegman K, Suppes T.
Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.
J Affect Disord. 1998 Jun;49(3):229-33.57: Sheldon LJ, Ancill RJ, Holliday SG.
Gabapentin in geriatric psychiatry patients.
Can J Psychiatry. 1998 May;43(4):422-3.58: Chouinard G, Beauclair L, Belanger MC.
Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders.
Can J Psychiatry. 1998 Apr;43(3):305.61: Watson WP, Robinson E, Little HJ. <
The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome.
Neuropharmacology. 1997 Oct;36(10):1369-75.62: Young LT, Robb JC, Patelis-Siotis I, MacDonald C, Joffe RT.
Acute treatment of bipolar depression with gabapentin.
Biol Psychiatry. 1997 Nov 1;42(9):851-3.64: McElroy SL, Soutullo CA, Keck PE, Kmetz GF. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder.
Ann Clin Psychiatry. 1997 Jun;9(2):99-103.65: Ryback RS, Brodsky L, Munasifi F.
Gabapentin in bipolar disorder.
J Neuropsychiatry Clin Neurosci. 1997 Spring;9(2):301.66: Schaffer CB, Schaffer LC.
Gabapentin in the treatment of bipolar disorder.
Am J Psychiatry. 1997 Feb;154(2):291-2.67: Stanton SP, Keck PE, McElroy SL.
Treatment of acute mania with gabapentin.
Am J Psychiatry. 1997 Feb;154(2):287.68: Singh L, Field MJ, Ferris P, Hunter JC, Oles RJ, Williams RG, Woodruff GN.
The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine.
Psychopharmacology (Berl). 1996 Sep;127(1):1-9.69: Dimond KR, Pande AC, Lamoreaux L, Pierce MW.
Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy.
Prog Neuropsychopharmacol Biol Psychiatry. 1996 Apr;20(3):407-17.
poster:SalArmy4me
thread:71671
URL: http://www.dr-bob.org/babble/20010720/msgs/71698.html